Print this page
-
Web-based Coping and Communication Skills Intervention for Women who are newly diagnosed with Gynecological cancer: A Pilot Study
Protocol: 131908Principal Investigator:
- Sharon Manne PhD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Ovary
Cervix -
Couple-Focused ACT Intervention for Couples Coping with Cancer: A Pilot Study
Protocol: 131604Principal Investigator:
- Sharon Manne PhD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Other Female Genital
Liver
Rectum
Colon
Melanoma, Skin
Ovary
Breast - Female
Cervix
Lung
Other Skin -
Cancer treatment and survivorship experiences among Southern New Jersey residents.
Protocol: 131803Principal Investigator:
- Sharon Manne PhD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Breast - Female
Colon
Melanoma, Skin
Ovary
Lung
Cervix
Other Female Genital
Rectum
Thyroid
Prostate
Urinary Bladder -
NCI/CTEP #9948: Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine with or without M6620 (VX-970) in First Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer.
Protocol: 051912Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Other Female Genital
Ovary -
NCI/CTEP #10150: A Randomized Phase 2 Study of Bevacizumab and Either Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant or Platinum Refractory Ovarian Cancer
Protocol: 101913Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Ovary -
NRG-GY005: A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women with Recurrent Platinum-Resistant or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS).
Protocol: 101905Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Other Female Genital
Ovary
